Blopress and Hyperammonaemia - a phase IV clinical study of FDA data

Summary:

Hyperammonaemia is reported as a side effect among people who take Blopress (candesartan cilexetil), especially for people who are female, 60+ old, also take Decadron, and have Pancreatic carcinoma.

The phase IV clinical study analyzes which people have Hyperammonaemia when taking Blopress. It is created by eHealthMe based on reports of 7,451 people who have side effects when taking Blopress from the FDA, and is updated regularly.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.

What is Hyperammonaemia?

Hyperammonaemia is found to be associated with 404 drugs and 559 conditions by eHealthMe. Check the latest studies of Hyperammonaemia.

On Jul, 12, 2026

7,451 people reported to have side effects when taking Blopress.
Among them, 11 people (0.15%) have Hyperammonaemia.

Among these 11 people:

What is the gender of people who have Hyperammonaemia when taking Blopress? *

female: 80 %
male: 20 %

What is the age of people who have Hyperammonaemia when taking Blopress? *

What are other drugs people take besides Blopress? *

What are other side effects people have besides Hyperammonaemia? *

Altered State Of Consciousness (altered state of mind): 3 people, 27.27%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 18.18%
Blood Urea Increased: 2 people, 18.18%
Renal Impairment (severely reduced kidney function): 2 people, 18.18%
Nausea And Vomiting: 2 people, 18.18%
Weakness: 1 person, 9.09%
Ascites (accumulation of fluid in the abdominal cavity): 1 person, 9.09%
Blood Sodium Decreased: 1 person, 9.09%
Blood Calcium Decreased: 1 person, 9.09%
Blood Bilirubin Increased: 1 person, 9.09%

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 4 people, 36.36%
Colon Cancer: 2 people, 18.18%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Oedema Due To Hepatic Disease (fluid collection in tissue due to liver disease): 1 person, 9.09%
Itching: 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 9.09%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Blopress and have Hyperammonaemia?

- Check whether Hyperammonaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blopress:

Blopress (7,479 reports)

Hyperammonaemia treatments and more:

Hyperammonaemia (6,053 reports)

Browse all side effects of Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperammonaemia:

Hyperammonaemia (404 drugs)

Browse all the conditions that are associated with Hyperammonaemia:

Hyperammonaemia (559 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Blopress) and Blopress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.